ClinConnect ClinConnect Logo
Search / Trial NCT05671484

TFPB vs QLB III in Infra-umbilical Pediatric Surgeries

Launched by NAMIK KEMAL UNIVERSITY · Dec 31, 2022

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Transversalis Fascial Plane Block Quadratus Lumborum Block Analgesia Pediatric Ultrasound Guidance

ClinConnect Summary

This clinical trial is comparing two methods of regional anesthesia called Transversalis Fascial Plane (TFP) block and Quadratus Lumborum (QL) block in children undergoing lower abdominal surgeries. The goal is to see which method provides better pain relief after surgery, helping kids recover faster and reducing the need for strong pain medications. Both techniques are used to numb the area around the surgery site, potentially leading to fewer side effects than traditional pain control methods like opioids.

To participate in the study, children must be between 3 and 7 years old and have a parent or guardian who agrees to let them join. They will also need to be scheduled for elective surgery in the lower abdomen and be in generally good health. Participants can expect to receive one of the two anesthesia techniques during their surgery, and their recovery will be monitored to see how well they manage pain afterward. It's important for parents to know that this study aims to improve pain management in young patients, making surgeries safer and more comfortable.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Parental acceptation to participate and signed written consent
  • Aged between 3 and 7
  • American Society of Anesthesiologists (ASA) physical score I or II
  • Elective infra umbilical surgery
  • Exclusion Criteria:
  • Parental refusal to participate
  • Known allergy to local anesthetics
  • American Society of Anesthesiologists (ASA) physical score ≥ III
  • Coagulopathy
  • Hypersensitivity history to the agents to be used
  • Local infections
  • Known anatomically or systemic disorder
  • Known growth and developmental retardation

About Namik Kemal University

Namik Kemal University is a leading academic institution dedicated to advancing research and education in the health sciences. With a commitment to innovation and excellence, the university actively sponsors clinical trials aimed at enhancing patient care and developing new therapeutic approaches. Leveraging its state-of-the-art facilities and a team of experienced researchers, Namik Kemal University fosters collaborative partnerships that drive scientific discovery and contribute to the body of knowledge in clinical medicine. Through its rigorous research programs, the university aims to improve health outcomes and address pressing medical challenges, making a significant impact on both local and global health communities.

Locations

Tekirdağ, , Turkey

Patients applied

0 patients applied

Trial Officials

Onur Baran, Asst. Prof.

Study Chair

Namik Kemal University

Ayhan Şahin, Asst. Prof.

Principal Investigator

Namik Kemal University

Cavidan Arar, Prof.

Study Director

Namik Kemal University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials